Viewing Study NCT05255302


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
Study NCT ID: NCT05255302
Status: RECRUITING
Last Update Posted: 2025-04-01
First Post: 2022-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-02
Start Date Type: ACTUAL
Primary Completion Date: 2025-05
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-06-01
Completion Date Type: ESTIMATED
First Submit Date: 2022-02-14
First Submit QC Date: None
Study First Post Date: 2022-02-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-26
Last Update Post Date: 2025-04-01
Last Update Post Date Type: ACTUAL